Analyst Recommendations

BMO Capital analyst issues OUTPERFORM recommendation for BKH on February 9, 2026 12:39PM ET. The previous analyst recommendation was Outperform.BKH was trading at $72.3 at issue of the...

February 9, 2026   BKH 0.20%

Citigroup analyst issues NEUTRAL recommendation for MO on February 9, 2026 11:50AM ET. The previous analyst recommendation was Neutral.MO was trading at $65.4 at issue of the analyst...

February 9, 2026   MO -0.63%

Barclays analyst issues UNDERWEIGHT recommendation for ITW on February 9, 2026 10:19AM ET. The previous analyst recommendation was Underweight.ITW was trading at $293.57 at issue of the analyst...

February 9, 2026   ITW 0.31%

Citigroup analyst issues BUY recommendation for SWK on February 6, 2026 11:25AM ET. The previous analyst recommendation was Buy.SWK was trading at $85.57 at issue of the analyst...

February 6, 2026   SWK 2.29%

Goldman Sachs analyst issues NEUTRAL recommendation for SWK on February 5, 2026 10:13PM ET. The previous analyst recommendation was Neutral.SWK was trading at $85.57 at issue of the...

February 5, 2026   SWK 2.29%

Citigroup analyst issues BUY recommendation for WMT on February 5, 2026 11:37AM ET. The previous analyst recommendation was Buy.WMT was trading at $128 at issue of the analyst...

February 5, 2026   WMT -1.62%

KeyBanc analyst issues OVERWEIGHT recommendation for EMR on February 5, 2026 11:56AM ET. The previous analyst recommendation was Overweight.EMR was trading at $157.32 at issue of the analyst...

February 5, 2026   EMR -1.81%

Barclays analyst issues OVERWEIGHT recommendation for SWK on February 5, 2026 10:48AM ET. The previous analyst recommendation was Overweight.SWK was trading at $84.63 at issue of the analyst...

February 5, 2026   SWK 2.29%

Deutsche Bank analyst issues HOLD recommendation for EMR on February 4, 2026 09:57PM ET. The previous analyst recommendation was Positive.EMR was trading at $157.32 at issue of the...

February 4, 2026   EMR -1.81%

Evercore ISI analyst issues OUTPERFORM recommendation for ABBV on February 4, 2026 07:35PM ET. The previous analyst recommendation was Outperform.ABBV was trading at $218.69 at issue of the...

February 4, 2026   ABBV 0.21%